TG Therapeutics, Inc. (TGTX) Q2 FY25 Earnings Call

Q2 FY25 results, source: company transcript and SEC filings
QuarterQ2 FY25
Call date2025-08-04
Length29 minutes
EPS$0.17
EPS consensus$0.32
Revenue$141.1M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26 · Q4 FY25

Read the full Q2 FY25 earnings call transcript

All TGTX earnings · Back to TGTX overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.